honokiol has been researched along with Atherogenesis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, P; Liu, Y; Wu, AH | 1 |
| Li, S; Qiu, L; Qu, Y; Sheng, H; Wang, S; Wu, J; Xu, R | 1 |
| Kim, CH; Lee, B; Moon, SK | 1 |
3 other study(ies) available for honokiol and Atherogenesis
| Article | Year |
|---|---|
Honokiol inhibits carotid artery atherosclerotic plaque formation by suppressing inflammation and oxidative stress.
Topics: Animals; Atherosclerosis; Biphenyl Compounds; Carotid Arteries; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Inflammation; Lignans; Male; Mice; Oxidative Stress; Plaque, Atherosclerotic; Signal Transduction | 2020 |
Honokiol ameliorates endothelial dysfunction through suppression of PTX3 expression, a key mediator of IKK/IκB/NF-κB, in atherosclerotic cell model.
Topics: Apoptosis; Atherosclerosis; Biphenyl Compounds; C-Reactive Protein; Down-Regulation; Drugs, Chinese Herbal; Human Umbilical Vein Endothelial Cells; Humans; I-kappa B Kinase; Lignans; Magnolia; NF-kappaB-Inducing Kinase; Palmitic Acid; Protein Serine-Threonine Kinases; Serum Amyloid P-Component; Signal Transduction | 2015 |
Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells.
Topics: Antineoplastic Agents, Phytogenic; Atherosclerosis; Base Sequence; Biphenyl Compounds; Cell Survival; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; G1 Phase; Humans; Imidazoles; Lignans; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Protein Kinases; Pyridines; Sequence Deletion | 2006 |